AstraZeneca (AZN) Announces FDA Acceptance of Sodium Zirconium Cyclosilicate NDA Resubmission
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 4/25/2024
- Wall Street stocks fall as weak GDP growth spreads rate-cut gloom
- Q1 US GDP shows surprise slowing and uncomfortable inflation
- Alphabet (GOOGL) soars 16% on Q1 results beat, first-ever dividend
- Meta shares dip on softer Q2 revenue guidance, elevated AI spending plans
- Oil settles higher as weak U.S. economic growth offset by supply concerns
- IBM tumbles on soft Q1 revenue; announces HashiCorp $6.4bn acquisition
- Hasbro (HAS) brand strength sees earnings top expectations
- Meta Platforms (META) Tops Q1 EPS by 39c, Offers Guidance
- Seagate Technology (STX) Enters $600M Asset Purchase Agreement with Avago
- Rubrik (RBRK) Prices Upsized 23.5M Share IPO at $32/sh
- After-hours movers: Alphabet, Microsoft, Snap, Intel, and more
- Midday movers: Meta, IBM, Caterpillar fall; Chipotle rises
- After-hours movers: Meta, Ford, IBM, ServiceNow and more
- Midday movers: Tesla, Boeing rise; Uber, Old Dominion Freight fall
- After-hours movers: Tesla, Texas Instruments, Seagate, Visa and more
AstraZeneca (AZN) Gains on Novartis (NVS) Chatter
October 17, 2016 11:06 AM EDTUpside in AstraZeneca (NYSE: AZN) is being attributed to a vague rumor that Novartis AG (NYSE: NVS) is looking to sell its 33.3% stake in Roche to make a cash bid for AstraZeneca.
AstraZeneca declined to comment on the speculation.
Shares of AZN are up 1.1%.
... MoreAstraZeneca (AZN) declines to comment on M&A speculation - Bloomberg, citing spokesperson
October 17, 2016 10:48 AM EDTAstraZeneca (NYSE: AZN) declines to comment on M&A speculation - Bloomberg, citing spokesperson
... MoreAstraZeneca (AZN) October calls active
October 17, 2016 10:29 AM EDTAstraZeneca (NYSE: AZN) October 30.5 and 31 calls are active on total call volume of 7,200 contacts (60 puts). October call option implied volatility is at 34, November is at 30; compared to its 52-week range of 33 to 74.
... More
